• Publications
  • Influence
Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir
Background:Switching from boosted protease inhibitors (PI/r) to raltegravir (RAL) results in a better plasma lipid profile than continuing PI/r. Whether this strategy affects plasma biomarkersExpand
  • 99
  • 3
La música de tu vida
Diseño de un brazo robótico guiado por cables
Statins upregulate microRNA-122 in HEPG2 cells